journal article·2021-06-09

Self-Adjuvant Effect by Manipulating the Bionano Interface of Liposome-Based Nanovaccines

Zhuxuan Jiang, Jican Liu, Juan Guan, Huan Wang, Tianhao Ding, Jun Qian, Changyou Zhan

Nano Letters· Volume 21· Issue 11
Publisher page

Abstract

Nanovaccines are of increasing scrutiny due to their plasticity in size, composition, and surface properties to enhance antigenicity. However, inevitable absorption of plasma proteins affects the in vivo fate of nanovaccines by reshaping biological identity. Herein IgM was validated as a self-adjuvant by regulating antigen-presenting cells recognition of liposome-based nanovaccines. D CDX-modified liposomes with loading of ovalbumin ( D CDX-sLip/OVA) heavily absorbed IgM via electrostatic interaction, demonstrating significant splenic B cells targeting. IgM absorbed on D CDX-sLip/OVA enhanced antigen uptake and presentation by both IgM-complement and IgM-FcμR pathways. D CDX-sLip/OVA induced a stronger IgG1 titer than ovalbumin-loaded plain liposomes (sLip/OVA) while maintaining a comparably high level of IgG2a titer with high biosafety, indicating that IgM absorption after D CDX modification could improve the antigenicity by enhancing the Th2-polarized immune response. The present work suggested manipulation of IgM absorption may provide a new impetus to improve in vivo performance of nanovaccines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology, School of Basic Medical Sciences & Center of Medical Research and Innovation, Shanghai Pudong Hospital & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200032, P.R. China

Department of Pathology, Affiliated Zhongshan Hospital Qingpu Branch, Fudan University, Shanghai 201700, P.R. China

School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education, Shanghai 201203, P.R. China

Funding

Natural Science Foundation of Shanghai · Education Department of Sichuan Province · National Natural Science Foundation of China · Shanghai Education Commission Major Project · Science and Technology Development Project of Qingpu District · Talent Training Plan of Qingpu District Health System

References (46)

Show source-provided references
1. 10.2174/138955751666616080110330310.2174/1389557516666160801103303 ↗
2. 10.1016/j.addr.2021.04.01510.1016/j.addr.2021.04.015 ↗
3. 10.1080/14760584.2019.157821610.1080/14760584.2019.1578216 ↗
4. 10.1016/j.canlet.2018.10.04410.1016/j.canlet.2018.10.044 ↗
5. 10.1080/1061186X.2018.156188610.1080/1061186X.2018.1561886 ↗
6. 10.1016/j.cell.2018.05.05910.1016/j.cell.2018.05.059 ↗
7. 10.1016/j.semcdb.2016.12.00110.1016/j.semcdb.2016.12.001 ↗
8. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
9. 10.1038/nnano.2012.23710.1038/nnano.2012.237 ↗
10. 10.1021/acs.biomac.5b0010810.1021/acs.biomac.5b00108 ↗
11. 10.2147/IJN.S7299810.2147/IJN.S72998 ↗
12. 10.1021/acs.molpharmaceut.8b0061210.1021/acs.molpharmaceut.8b00612 ↗
13. 10.1038/s41565-018-0344-310.1038/s41565-018-0344-3 ↗
14. 10.1038/nnano.2015.33010.1038/nnano.2015.330 ↗
15. 10.1016/j.jconrel.2021.04.02510.1016/j.jconrel.2021.04.025 ↗
16. 10.1016/S0161-5890(01)00025-610.1016/S0161-5890(01)00025-6 ↗
17. 10.1038/s41577-019-0168-x10.1038/s41577-019-0168-x ↗
18. 10.3389/fimmu.2019.0052910.3389/fimmu.2019.00529 ↗
19. 10.1038/s41467-018-05384-110.1038/s41467-018-05384-1 ↗
20. 10.1016/j.jconrel.2020.01.01810.1016/j.jconrel.2020.01.018 ↗
21. 10.1002/anie.20141122610.1002/anie.201411226 ↗
22. 10.1038/nature0590110.1038/nature05901 ↗
23. 10.1021/acsnano.0c0282110.1021/acsnano.0c02821 ↗
24. 10.1016/j.jconrel.2020.12.04710.1016/j.jconrel.2020.12.047 ↗
25. 10.1007/s00441-010-1034-010.1007/s00441-010-1034-0 ↗
26. 10.1039/C8BM01340C10.1039/C8BM01340C ↗
27. 10.1128/JVI.77.4.2578-2586.200310.1128/JVI.77.4.2578-2586.2003 ↗
28. 10.1007/s12185-020-02912-y10.1007/s12185-020-02912-y ↗
29. 10.1111/j.1600-065X.2000.imr017515.x10.1111/j.1600-065X.2000.imr017515.x ↗
30. 10.1016/j.coi.2019.04.00310.1016/j.coi.2019.04.003 ↗
31. 10.4049/jimmunol.110210710.4049/jimmunol.1102107 ↗
32. 10.1084/jem.2005103810.1084/jem.20051038 ↗
33. 10.1093/intimm/dxu07010.1093/intimm/dxu070 ↗
34. 10.1016/j.cellimm.2020.10406110.1016/j.cellimm.2020.104061 ↗
35. 10.1046/j.1440-1711.1999.00835.x10.1046/j.1440-1711.1999.00835.x ↗
36. 10.1146/annurev.immunol.23.021704.11561110.1146/annurev.immunol.23.021704.115611 ↗
37. 10.1146/annurev.iy.11.040193.00155510.1146/annurev.iy.11.040193.001555 ↗
38. 10.1016/j.humimm.2018.04.01310.1016/j.humimm.2018.04.013 ↗
39. 10.1128/IAI.63.12.4557-4563.199510.1128/IAI.63.12.4557-4563.1995 ↗
40. 10.1038/s41598-017-11399-310.1038/s41598-017-11399-3 ↗
41. 10.1038/s41586-019-1817-810.1038/s41586-019-1817-8 ↗
42. 10.1016/S1081-1206(10)62426-X10.1016/S1081-1206(10)62426-X ↗
43. 10.1038/nri383110.1038/nri3831 ↗
44. Kidd P. · Altern. Med. Rev. · 2003 · 8 · 223
45. 10.1038/nri347610.1038/nri3476 ↗
46. 10.3389/fimmu.2019.0123410.3389/fimmu.2019.01234 ↗